<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03592784</url>
  </required_header>
  <id_info>
    <org_study_id>1802018956</org_study_id>
    <nct_id>NCT03592784</nct_id>
  </id_info>
  <brief_title>Food Order Intervention for Gestational Diabetes</brief_title>
  <official_title>Carbohydrate-Last Food Order Intervention for Gestational Diabetes Mellitus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Weill Medical College of Cornell University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Weill Medical College of Cornell University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized controlled feasibility trial for women diagnosed with gestational
      diabetes mellitus (GDM). The current front-line treatment for GDM is medical nutrition
      therapy (MNT), i.e. personalized diets which may or may not include mild carbohydrate
      restriction. Use of carbohydrate restriction increases the risk of the mother developing
      ketosis, a harmful condition for both the mother and fetus. If MNT is not enough to stabilize
      blood sugar levels, then pharmaceuticals are prescribed. In patients with type-2 diabetes and
      prediabetes, the carbohydrate-last food order behavior has been shown to improve post-meal
      blood sugar control without the need of reduced carbohydrate intake. Given this data, the
      addition of this intervention to MNT in patients with GDM may be helpful in achieving
      controlled blood sugar levels without increasing the risk of ketosis. This study will include
      two randomized groups diagnosed with GDM. Patients in the control group will be prescribed
      standard MNT. Patients in the intervention group will have identical MNT but with additional
      food order instruction/therapy. All patients will be followed up with at 1-2 week intervals.
      At each follow-up the physician and dietician will analyze the patient's blood sugar
      measurements and, among additional factors, determine if pharmaceuticals should be added.
      Treatment will continue through delivery. The primary aim of this study is to assess the
      feasibility of the carbohydrate last food order in GDM and generate preliminary data on its
      effects on glucose control.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 18, 2018</start_date>
  <completion_date type="Anticipated">July 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Feasibility of the Food Order Intervention</measure>
    <time_frame>8 weeks</time_frame>
    <description>Measured via feasibility questionnaire.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Average 1-hour postprandial glucose</measure>
    <time_frame>2, 4, 6, 8, 10, 12 weeks</time_frame>
    <description>Averaged from self-monitored blood glucose logs.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to initiation of pharmacotherapy</measure>
    <time_frame>2, 4, 6, 8, 10, 12 weeks</time_frame>
    <description>Measured in weeks from enrollment in the study.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients requiring the addition of pharmacotherapy</measure>
    <time_frame>Week 16 or End of study (at delivery)</time_frame>
    <description>Measured as a percentage of patients in each arm.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Birthweight</measure>
    <time_frame>Week 16 or End of study (delivery)</time_frame>
    <description>Measured in lbs.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Gestational Diabetes</condition>
  <arm_group>
    <arm_group_label>Food Order Therapy + Medical Nutrition Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Medical Nutrition Therapy Alone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Food Order Therapy</intervention_name>
    <description>Instructing patient to, whenever possible, eat carbohydrates at the end of their meal.</description>
    <arm_group_label>Food Order Therapy + Medical Nutrition Therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Medical Nutrition Therapy</intervention_name>
    <description>Key components of this therapy include counseling to incorporate portion control, increased intake of vegetables and low glycemic index carbohydrates, and mild carbohydrate restriction.</description>
    <arm_group_label>Food Order Therapy + Medical Nutrition Therapy</arm_group_label>
    <arm_group_label>Medical Nutrition Therapy Alone</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant subjects â‰¥18 years old

          -  Newly diagnosed with GDM between 24-32 weeks of gestation with at least 2 days of
             self-monitored glucose logs or diagnosed via a 50g glucose challenge test (GCT)
             greater than 200mg/dL

        Exclusion Criteria:

          -  Pre-existing diabetes prior to conception

          -  Patients whom do not plan on consuming at least 3 meals daily throughout gestation
             (e.g. during Ramadan)

          -  Requirement of special medical diet (e.g. from phenylketonuria, celiac disease, etc.)

          -  History of bariatric surgery
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alpana P Shukla, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Weill Cornell Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Wanda Truong, MS</last_name>
    <phone>646-962-2423</phone>
    <email>wat7003@med.cornell.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Materal-Fetal Medicine of Weill Cornell Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wanda Truong, MS</last_name>
      <phone>646-962-2423</phone>
      <email>wat7003@med.cornell.edu</email>
    </contact>
    <investigator>
      <last_name>Nancy E Addison, RD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Louis J Aronne, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joshua B Cadwell</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anthony J Casper</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Shari Gelber, MD/PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ampadi Karan</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Karen Lin</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Brienne C Lubor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kathy Matthews, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Felicia A Mendelsohn Curanaj</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Wanda Truong, MS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>June 18, 2018</study_first_submitted>
  <study_first_submitted_qc>July 17, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 19, 2018</study_first_posted>
  <last_update_submitted>July 26, 2019</last_update_submitted>
  <last_update_submitted_qc>July 26, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 29, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes, Gestational</mesh_term>
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

